Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

7-ethyl-10-hydroxycamptothecin-derived prodrug-encapsulated polymer nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

1

poly(ethylene glycol)-block-poly(D,L-lactic acid)

PEG5K-PLA16K
Type Polymer
Formula
Role carriers
2

(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl 2-{[(tert-butoxy)carbonyl]amino}acetate

Type Single Compound
Formula C29H31N3O8
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug release

1 more entry available to subscribers only.

Or, view sample content

Applications

Area Application Source
medicine/veterinary

0 more entry available to subscribers only.

Or, view sample content

Characterization

Method Source
transmission electron microscopy

0 more entry available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
HCT-116 colorectal xenograft mouse

4 more entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(ethylene glycol)-block-poly(D,L-lactic acid)
  • (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl 2-{[(tert-butoxy)carbonyl]amino}acetate
  1. 2S1BMs5UcsMG
  2. QjXXU
Product

7-ethyl-10-hydroxycamptothecin-derived prodrug-encapsulated polymer nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial